NRX Pharmaceuticals (NRXP)

• Market cap: $54.5M
• 1 day: 0%
• 5 days: 6.36%
• 1 month: -15.6%
• 3 months: -9.36%
• 6 months: -29.77%
• Year to date: -29.77%
• 1 year: -24.9%
• 5 years: -99.49%
• 10 years: -98.08%
• Sector: Healthcare
• Industry: Biotechnology

About: NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.